08:47 AM EDT, 07/15/2024 (MT Newswires) -- Lenz Therapeutics ( LENZ ) said Monday that it has signed a stock purchase agreement with Ridgeback Capital Investments for a $30 million private investment in public equity common stock financing.

The company said it plans to use the net proceeds from the financing toward supporting the regulatory, pre-commercial, and potential commercial launch activities for LNZ100, a potential therapy for presbyopia.

Lenz said the net proceeds would also be used for working capital and general corporate purposes.

Price: 21.19, Change: +0.16, Percent Change: +0.76